Literature DB >> 2073115

Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin.

H M Wexler1, P T Lavin, E Molitoris, S M Finegold.   

Abstract

A pilot study was designed to estimate the variance components in the determination of the MIC of cefoxitin for isolates of the Bacteroides fragilis group. Twenty different organisms were tested, and replicate, trial, and reader variabilities were examined. When the total-variance component was used, if the true MIC was 16 micrograms/ml, then the chance that the observed MIC was between 8 and 32 micrograms/ml, inclusive, was 95%. For all analyses, the isolate (P = 0.0001) and reader (P less than 0.03) effects were significant. The probability of specific MIC observations for various true MICs (over the range of 16 to 32 micrograms/ml at 4-micrograms/ml increments) was calculated. For true MICs of 20, 24, and 28 micrograms/ml, the probabilities of observing an MIC of 16 or 32 micrograms/ml (inclusive) were 86, 75, and 62%, respectively. An upward bias was shown to exist in addition to sources of sizeable variation. The recommendation stemming from recognition of this inherent variability is that ranges of percent susceptibility at various concentrations be included in reports of in vitro susceptibility studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073115      PMCID: PMC172030          DOI: 10.1128/AAC.34.11.2246

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Cell-wall-defective variants of Fusobacterium.

Authors:  C C Johnson; H M Wexler; S Becker; M Garcia; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 2.  Antimicrobial resistance in Bacteroides.

Authors:  H M Wexler; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

Review 3.  In vitro activity of imipenem against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
  3 in total
  7 in total

Review 1.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; F Jashnian; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

3.  Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.

Authors:  H M Wexler; E Molitoris; P R Murray; J Washington; R J Zabransky; P H Edelstein; S M Finegold
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Authors:  P Turgeon; V Turgeon; M Gourdeau; J Dubois; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

5.  Inhibition of species of the Aspergillus section Nigri and ochratoxin a production in grapes by fusapyrone.

Authors:  Mara Favilla; Michelangelo Pascale; Alessandra Ricelli; Antonio Evidente; Carmine Amalfitano; Claudio Altomare
Journal:  Appl Environ Microbiol       Date:  2008-02-08       Impact factor: 4.792

6.  In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations.

Authors:  Elodie A Lallemand; Marlène Z Lacroix; Pierre-Louis Toutain; Séverine Boullier; Aude A Ferran; Alain Bousquet-Melou
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

7.  Variability of Beta-Lactam Broth Microdilution for Pseudomonas aeruginosa.

Authors:  A A Bhalodi; N Oppermann; S A Campeau; R M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.